Systematic Review

Published on 31 May 2023

Immunotherapy for ocular melanoma: a bibliometric and visualization analysis from 1991 to 2022

in Cancer Immunity and Immunotherapy

Yao Tan
Yijie Lu
Sheng Chen
Chang Zou
Bo Qin

Frontiers in Oncology

doi 10.3389/fonc.2023.1161759

3,812 views
1 citation

Original Research

Published on 30 May 2023

Comprehensive analysis of the prognosis and immune effect of the oncogenic protein Four Jointed Box 1

in Cancer Immunity and Immunotherapy

Mei Huang
Tian Guo
Yan Meng
Ruling Zhou
Man Xiong
Jian Ding
Yali Zhang
Side Liu
Kangmin Zhuang

Frontiers in Oncology

doi 10.3389/fonc.2023.1170482

1,949 views

Original Research

Published on 30 May 2023

Afatinib combined with anti-PD1 enhances immunotherapy of hepatocellular carcinoma via ERBB2/STAT3/PD-L1 signaling

in Cancer Immunity and Immunotherapy

Chao Yu
Xinyi Zhang
Min Wang
Gaoxin Xu
Siqi Zhao
Yongheng Feng
Chao Pan
Weijun Yang
Jin Zhou
Longcheng Shang

Frontiers in Oncology

doi 10.3389/fonc.2023.1198118

2,331 views
6 citations

Review

Published on 25 May 2023

Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Shuqi Xie
Mengchao Wang
Chuanxiu Zeng
Yan Ou
Lu Zhao
Dong Wang
Liwei Chen
Fanming Kong
Dan Yi

Frontiers in Oncology

doi 10.3389/fonc.2023.1197698

1,800 views
4 citations

Original Research

Published on 25 May 2023

Identification of a novel signature based on macrophage-related marker genes to predict prognosis and immunotherapeutic effects in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Yuanshuai Su
Chen Xue
Xinyu Gu
Wankun Wang
Yu Sun
Renfang Zhang
Lanjuan Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1176572

3,643 views
5 citations

Review

Published on 23 May 2023

Could the tumor-associated microbiota be the new multi-faceted player in the tumor microenvironment?

in Cancer Immunity and Immunotherapy

Anne-Gaëlle Goubet

Frontiers in Oncology

doi 10.3389/fonc.2023.1185163

2,677 views
5 citations

Original Research

Published on 23 May 2023

Mediating immunosuppressive functions: a new perspective on the complex immunological properties of SEMA4D in the tumor microenvironment

in Cancer Immunity and Immunotherapy

Shujie Zeng
Zihao Zhang
Chunshui Ye
Jinshen Wang
Changqing Jing
Leping Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1171926

2,285 views

Case Report

Published on 22 May 2023

Case Report: IBD-like colitis following CAR T cell therapy for diffuse large B cell lymphoma

in Cancer Immunity and Immunotherapy

Sebastian Zundler
Francesco Vitali
Soraya Kharboutli
Simon Völkl
Iris Polifka
Andreas Mackensen
Raja Atreya
Markus F. Neurath
Dimitrios Mougiakakos

Frontiers in Oncology

doi 10.3389/fonc.2023.1149450

5,500 views
5 citations

Review

Published on 19 May 2023

Deciphering immune microenvironment and cell evasion mechanisms in human gliomas

in Cancer Immunity and Immunotherapy

Soumaya Rafii
Sarah Kandoussi
Amina Ghouzlani
Oumayma Naji
Konala Priyanka Reddy
Rizwan Ullah Sadiqi
Abdallah Badou

Frontiers in Oncology

doi 10.3389/fonc.2023.1135430

3,922 views
5 citations

Original Research

Published on 18 May 2023

Blood immune cells as potential biomarkers predicting relapse-free survival of stage III/IV resected melanoma patients treated with peptide-based vaccination and interferon-alpha

in Cancer Immunity and Immunotherapy

Federica Moschella
Carla Buccione
Irene Ruspantini
Luciano Castiello
Andrea Rozo Gonzalez
Floriana Iacobone
Virginia Ferraresi
Belinda Palermo
Paola Nisticò
Filippo Belardelli

Frontiers in Oncology

doi 10.3389/fonc.2023.1145667

1,600 views
1 citation

Original Research

Published on 18 May 2023

Levels of oxidative stress in patients with neoadjuvant chemotherapy for gastric cancer: correlation with treatment response

in Cancer Immunity and Immunotherapy

Jiatong Lu
Shaoyu Guan
Jiajun Luo
Jingwen Yuan
Junfeng Yan
Chen Yang
Qiang Tong

Frontiers in Oncology

doi 10.3389/fonc.2023.1192192

1,571 views
3 citations

Original Research

Published on 16 May 2023

Identification of DNA repair gene signature and potential molecular subtypes in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Yi Bai
Jinyun He
Yanquan Ma
He Liang
Ming Li
Yan Wu

Frontiers in Oncology

doi 10.3389/fonc.2023.1180722

1,571 views

Original Research

Published on 16 May 2023

The efficacy and safety of lenvatinib plus transarterial chemoembolization in combination with PD-1 antibody in treatment of unresectable recurrent hepatocellular carcinoma: a case series report

in Cancer Immunity and Immunotherapy

Chunyang Mu
Junyi Shen
Xinrui Zhu
Wei Peng
Xiaoyun Zhang
Tianfu Wen

Frontiers in Oncology

doi 10.3389/fonc.2023.1096955

1,698 views
3 citations

Original Research

Published on 12 May 2023

Metabolic syndrome is independently associated with improved overall survival to first-line therapy with immune checkpoint inhibitors in non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Maroun Bou Zerdan
Prashanth Ashok Kumar
Dulce M. Barrios
Alanna Glidden
Dayana Nasr
Stephanie Niforatos
Ghanshyam Ghelani
Jennifer Leibovitch
Sandy Nasr
Binod KC

Frontiers in Oncology

doi 10.3389/fonc.2023.1134824

1,350 views

Original Research

Published on 12 May 2023

Cost-effectiveness of sacituzumab govitecan in hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer

in Cancer Immunity and Immunotherapy

Demin Shi
Yan Li
Xueyan Liang
Lingyuan Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1162360

2,331 views
5 citations

Case Report

Published on 10 May 2023

Multi-protocol exploratory treatment for metastatic castration-resistant prostate cancer with BRCA mutations: a case report and literature review

in Cancer Immunity and Immunotherapy

Dongsheng Zhao
Wen Su
Liang Zeng
Guoqian Hu
Jin Tang

Frontiers in Oncology

doi 10.3389/fonc.2023.1177941

1,809 views
1 citation

Navigation group

Articles

Immunotherapy for ocular melanoma: a bibliometric and visualization analysis from 1991 to 2022

Comprehensive analysis of the prognosis and immune effect of the oncogenic protein Four Jointed Box 1

Afatinib combined with anti-PD1 enhances immunotherapy of hepatocellular carcinoma via ERBB2/STAT3/PD-L1 signaling

Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma

Identification of a novel signature based on macrophage-related marker genes to predict prognosis and immunotherapeutic effects in hepatocellular carcinoma

Could the tumor-associated microbiota be the new multi-faceted player in the tumor microenvironment?

Mediating immunosuppressive functions: a new perspective on the complex immunological properties of SEMA4D in the tumor microenvironment

Case Report: IBD-like colitis following CAR T cell therapy for diffuse large B cell lymphoma

Deciphering immune microenvironment and cell evasion mechanisms in human gliomas

Blood immune cells as potential biomarkers predicting relapse-free survival of stage III/IV resected melanoma patients treated with peptide-based vaccination and interferon-alpha

Levels of oxidative stress in patients with neoadjuvant chemotherapy for gastric cancer: correlation with treatment response

Identification of DNA repair gene signature and potential molecular subtypes in hepatocellular carcinoma

The efficacy and safety of lenvatinib plus transarterial chemoembolization in combination with PD-1 antibody in treatment of unresectable recurrent hepatocellular carcinoma: a case series report

Metabolic syndrome is independently associated with improved overall survival to first-line therapy with immune checkpoint inhibitors in non-small cell lung cancer

Cost-effectiveness of sacituzumab govitecan in hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer

Multi-protocol exploratory treatment for metastatic castration-resistant prostate cancer with BRCA mutations: a case report and literature review